The association between drospirenone and hyperkalemia: a comparative-safety study
Steven T. Bird(United States Food and Drug Administration), Joseph A. Delaney(Center for Drug Evaluation and Research), James M. Brophy(McGill University Health Centre), Mahyar Etminan(Oncolytics Biotech (Canada)), Salvatore Pepe(Center for Drug Evaluation and Research), Xinyue Liu(Zhejiang A & F University)
Cited by 28
Related Papers
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93
Risk of acute kidney injury associated with the use of fluoroquinolones
|Canadian Medical Association Journal|2013|89
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2022|89